Antibacterial Activity of Isobavachalcone (IBC) Is Associated with Membrane Disruption

• Autor(a) principal: de Assis, Leticia Ribeiro [UNESP]
• Data de Publicação: 2022
• Outros Autores: Theodoro, Reinaldo Dos Santos [UNESP], Costa, Maria Beatriz Silva [UNESP], Nascentes, Julyanna Andrade Silva [UNESP], da Rocha, Miguel Divino [UNESP], Bessa, Meliza Arantes de Souza, Menezes, Ralciane de Paula, Dilarri, Guilherme [UNESP], Hypolito, Giovane Böerner [UNESP], Dos Santos, Vanessa Rodrigues [UNESP], Duque, Cristiane [UNESP], Ferreira, Henrique [UNESP], Martins, Carlos Henrique Gomes, Regasini, Luis Octavio [UNESP]
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://dx.doi.org/10.3390/membranes12030269; http://hdl.handle.net/11449/230485
• topic: Antibacterial; Biofilm; Chalcone; Membrane; Natural product

Isobavachalcone (IBC) is a natural prenylated chalcone with a broad spectrum of pharmacological properties. In this work, we newly synthesized and investigated the antibacterial activity of IBC against Gram-positive, Gram-negative and mycobacterial species. IBC was active against Grampositive bacteria, mainly against Methicillin-Susceptible Staphylococcus aureus (MSSA) and MethicillinResistant Staphylococcus aureus (MRSA), with minimum inhibitory concentration (MIC) values of 1.56 and 3.12 µg/mL, respectively. On the other hand, IBC was not able to act against Gram-negative species (MIC > 400 µg/mL). IBC displayed activity against mycobacterial species (MIC = 64 µg/mL), including Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium kansasii. IBC was able to inhibit more than 50% of MSSA and MRSA biofilm formation at 0.78 µg/mL. Its antibiofilm activity was similar to vancomycin, which was active at 0.74 µg/mL. In order to study the mechanism of the action by fluorescence microscopy, the propidium iodide (PI) and SYTO9 fluorophores indicated that IBC disrupted the membrane of Bacillus subtilis. Toxicity assays using human keratinocytes (HaCaT cell line) showed that IBC did not have the capacity to reduce the cell viability. These results suggested that IBC is a promising antibacterial agent with an elucidated mode of action and potential applications as an antibacterial drug and a medical device coating.